Skip to main content
. Author manuscript; available in PMC: 2020 Jun 29.
Published in final edited form as: Nature. 2019 Nov 20;575(7784):669–673. doi: 10.1038/s41586-019-1769-z

Figure 2: Loss of NLRP3 inflammasome function decreases tau pathology and improves cognition.

Figure 2:

a, Immunohistochemical staining for phosphorylated tau (AT8) in mouse hippocampi. Scale bar, 500μm.

b, Quantification of AT8 in hippocampus and CA1 region shown in a. n=17 for Tau22, n=15 for Tau22/Asc−/−, n=8 for Tau22/Nlrp3−/−. Hippocampus: **P=0.0055, CA1: *P=0.0278, **P=0.0059.

c, Staining with thioflavine S (aggregated Tau) of mouse hippocampi. Scale bar, 500μm (top) and 100μm (bottom).

d, Quantification of thioflavine S-positive cells in CA1 region shown in c. n=12 for Tau22, n=5 for Tau22/Asc−/− and Tau22/Nlrp3−/−. Tau22 vs. Tau22/Asc−/−: *P=0.0240, Tau22 vs. Tau22/Nlrp3−/−: *P=0.0444.

e, Example of movement of mice in Morris water maze test (MWM).

f, Quantification of time spend in quadrant 1 (Q1) vs. all other quadrants (a.o.) in MWM. n=12 for WT, Nlrp3−/−, Tau22/Asc−/−, Tau22/Nlrp3−/−, n=14 for Asc−/−, n=16 for Tau22. ***P=0.0001, ****P<0.0001, Asc−/−: **P=0.0065, Nlrp3−/−: **P=0.0012. For gel source data, see Supplementary Figure 1. Data are mean ± SEM and were analyzed by one-way ANOVA with Tukey’s test (b, d) or two-tailed unpaired t-test (f).